首页>
外国专利>
Composition for transdermal or transmucosal dosage form comprising a Weight ratio of buprenorphine naloxone between 2.1 and 8: 1: 1, useful for the treatment of pain.
Composition for transdermal or transmucosal dosage form comprising a Weight ratio of buprenorphine naloxone between 2.1 and 8: 1: 1, useful for the treatment of pain.
展开▼
机译:用于治疗疼痛的丁丙诺啡纳洛酮的重量比为2.1至8:1:1的透皮或透粘膜剂型的组合物。
展开▼
页面导航
摘要
著录项
相似文献
摘要
There is provided a composition for the treatment of pain in human patients wherein said composition comprises buprenorphine to naloxone in a ratio by weight of from 2.1:1 to 8:1, the amount of buprenorphine and naloxone being suitable to provide analgesia, the composition being in a transdermal or transmucosal dosage form. Also provided are an associated method and use.
展开▼